Forward Pharma A/S (NASDAQ:FWP) has analysts on the Bullish side this week.

February 15, 2018 - By Marie Mckinney

 Forward Pharma A/S (NASDAQ:FWP) has analysts on the Bullish side this week.

Forward Pharma A/S (NASDAQ:FWP) Ratings Coverage

Among 3 analysts covering Forward Pharma (NASDAQ:FWP), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Forward Pharma had 10 analyst reports since September 9, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Wednesday, September 9. JMP Securities maintained the shares of FWP in report on Wednesday, March 9 with “Market Outperform” rating. The firm has “Hold” rating by Jefferies given on Tuesday, September 26. The firm has “Hold” rating by Jefferies given on Monday, April 3. The firm has “Market Perform” rating given on Monday, April 3 by JMP Securities. On Monday, June 26 the stock rating was maintained by Jefferies with “Hold”. The stock has “Hold” rating by Jefferies on Friday, October 27. Below is a list of Forward Pharma A/S (NASDAQ:FWP) latest ratings and price target changes.

27/10/2017 Broker: Jefferies Rating: Hold New Target: $6.0 Maintain
26/09/2017 Broker: Jefferies Rating: Hold New Target: $6.0 Maintain

The stock increased 1.53% or $0.05 during the last trading session, reaching $3.32. About 14,746 shares traded. Forward Pharma A/S (NASDAQ:FWP) has risen 4.69% since February 15, 2017 and is uptrending. It has underperformed by 12.01% the S&P500.

Forward Pharma A/S operates as a biopharmaceutical company. The company has market cap of $156.65 million. The firm focuses on developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. It has a 0.17 P/E ratio.

More notable recent Forward Pharma A/S (NASDAQ:FWP) news were published by: Seekingalpha.com which released: “Forward Pharma loses challenge to European patent covering dimethyl fumarate …” on January 29, 2018, also Fool.com with their article: “Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today” published on March 31, 2017, Globenewswire.com published: “Forward Pharma Reports Financial and Operational Results from the First Six …” on September 26, 2017. More interesting news about Forward Pharma A/S (NASDAQ:FWP) were released by: Nasdaq.com and their article: “Forward Pharma A/S (FWP) Ex-Dividend Date Scheduled for September 12, 2017” published on September 11, 2017 as well as Globenewswire.com‘s news article titled: “Forward Pharma Reports Fourth Quarter and Year End 2016 Financial and …” with publication date: April 18, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.